Equivalent price position
This pack size cannot yet be normalized reliably for a unit-price comparison. MedInfoBase does not estimate unit prices from ambiguous pack descriptions.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Sofosbuvir + Velpatasvir
- Therapeutic area
- Anti-infectives
- Drug class
- Antivirals
- ATC
- J05AP
- Strength
- 100 mg + 400 mg
- Dosage form
- Tablet
- Pack
- 28's (patient)
- Registration no.
- 088368
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-11-12 02:58
Manufacturer
Ferozsons Laboratories Limited
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →What Epclusa (Sofosbuvir-velpatasvir) is used for
Sofosbuvir-velpatasvir is a single tablet that contains two antiviral medicines for hepatitis C. Both stop the hepatitis C virus from copying itself, each in a different way. It belongs to a group of hepatitis C medicines called direct-acting antivirals, and it works against all the main types (genotypes) of the virus. Treatment is decided on and started by a specialist hepatitis C team, who check your progress with blood tests. Most people who complete treatment are cured. Young children may be given it as small pellets instead of tablets.
- Long-term (chronic) hepatitis C infection in adults and children aged 3 and over
- All the main types of hepatitis C virus (genotypes 1 to 6)
- People with or without scarring of the liver (cirrhosis)
- People with advanced cirrhosis where the liver is no longer working well (decompensated cirrhosis), together with another medicine called ribavirin. Ribavirin is sometimes added in other situations too.
Get medical help straight away if
- Get emergency help for swelling of the face, lips, tongue or throat, which can make it hard to breathe or swallow.
- Get urgent medical help for a severe, widespread rash with blisters or peeling skin.
- If you take, or have recently taken, the heart medicine amiodarone, get urgent help for a slow or irregular heartbeat, a pounding heart, chest pain, breathlessness, feeling light-headed or fainting. The two medicines together can slow the heartbeat dangerously.
- Call your doctor straight away for signs that hepatitis B may be flaring up: unusual tiredness, yellow skin or eyes, loss of appetite, feeling or being sick, pale stools, stomach pain or dark urine. This can happen during or after treatment in people who have ever had hepatitis B.
Side effects, warnings and interactions for Sofosbuvir-velpatasvir
Prepared from the sources listed by the MedInfoBase team. General information, not medical advice: it gives no doses. Your doctor or pharmacist decides the medicine and dose for you.
Our condition guides that mention Sofosbuvir + Velpatasvir
From our condition guides, written from WHO, NICE and other opened sources. Your doctor decides if Sofosbuvir + Velpatasvir is right for you and the dose.
- Hepatitis C: recommended pangenotypic treatment for adults with or without compensated cirrhosis
About Epclusa 100 mg + 400 mg tablet
Epclusa 100 mg + 400 mg tablet contains Sofosbuvir + Velpatasvir 100 mg + 400 mg. It is registered with DRAP by Ferozsons Laboratories Limited (registration no. 088368). Its official price is PKR 61,317.23 for a pack of 28's (patient). This price has applied since 22 July 2026. It is sold in 2 pack sizes: 28's (patient) and 28's. 2 other brands of Sofosbuvir + Velpatasvir 100 mg + 400 mg (tablet) are registered in Pakistan. Compare all brands and prices →
Epclusa 100 mg + 400 mg pack sizes and prices
| Pack | Official price | Per tablet |
|---|---|---|
| 28's (patient) (this page) | PKR 61,317.23 | — |
| 28's | PKR 72,137.00 | PKR 2,576.32 |
All 2 other brands of Sofosbuvir + Velpatasvir 100 mg + 400 mg tablet in Pakistan
These 2 brands are alternatives (substitutes) to Epclusa: each contains Sofosbuvir + Velpatasvir 100 mg + 400 mg tablet. Ask your doctor or pharmacist before you switch brands.
Sorted by price per tablet, lowest first. The lowest is VELSOVIR 100mg (Atco Laboratories Limited) at PKR 659 per tablet; the highest is VELSOVIR at PKR 659. All prices are official DRAP prices.
| Brand | Company | Pack | Official price | Per unit |
|---|---|---|---|---|
| VELSOVIR 100mg | Atco Laboratories Limited | 7s | PKR 4,616.46 | PKR 659 / tablet |
| VELSOVIR | Atco Laboratories Limited | 14s | PKR 9,232.93 | PKR 659 / tablet |
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Epclusa, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- Ferozsons Laboratories Limited, Lahore
- DRAP registration
- 088368
- Phone
- +92 42 36026700
- info@ferozsons-labs.com
- Website
- https://ferozsons-labs.com/
- Contact page
- Company contact page
Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
No change in the official DRAP price is recorded for this pack (28's (patient)). Current price PKR 61,317.23, effective 22 Jul 2026.
Cite this price history
MedInfoBase. Epclusa 100 mg + 400 mg, 28's (patient): official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/epclusa-100-mg-400-mg-088368-28s-ferozsons-laboratories-limited/ (accessed 12 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 61,317.23 | 2026-07-22 | 2026-08-08 | DRAP PharmaPrice Index | Current |
Cite this record
Medicine record · DRAP registration 088368Price and registration data on this page were observed on 8 August 2026. Records change over time, so please cite the observation date alongside the access date.